 |
|
|
|
|
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Cambrex Corporation
| | | | | Phone: | (201) 804-3000 | | Fax: | (201) 804-9852 | | Year Established: | 1981 | | Ticker: | CBM | | Exchange: | NYSE | | Main Contact: | Gregory P. Sargen, Executive VP, Corporate Development & Strategy | | | | Other Contacts: | Tom Vadaketh, Executive VP & CFO
Samantha M Hanley, VP & General Counsel
Shawn P Cavanagh, Executive VP & COO
Steven M. Klosk, President & CEO
| | | | Company Description | | Cambrex, formerly CasChem, is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. Theyoffer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Their development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. | |
|
|
|
|
|
|
|
